Astellas Pharma sentencing highlights China risks for corporate Japan

2 years after detention, companies have defense measures in place

20250716N China surveillance

China revised its Anti-Espionage Law in July 2023, expanding the scope of targets for espionage. (Photo by Tomoki Mera)

KOHEI FUJIMURA

DALIAN, China -- China's sentencing of a Japanese employee of Astellas Pharma on espionage charges serves as a stark reminder of the risks to doing business in the country and the need for precautionary measures to protect corporate employees.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.